2026-2030年全球肉毒桿菌市場

全球肉毒桿菌市場預計在 2025 年至 2030 年間成長至 62.159 億美元，預測期內複合年成長率為 10.7%。

本報告對全球肉毒桿菌市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動該市場成長的因素包括：全球對微創美容手術需求的不斷成長、獲批療法和臨床應用的快速擴展、人口結構變化以及老年預防性護理的興起。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告包含歷史數據和預測數據。

本研究指出，即用型液體製劑和新一代調變器的廣泛應用將成為未來幾年全球肉毒桿菌市場成長的主要驅動力之一。此外，全臉輪廓塑形和微劑量注射技術的普及，以及預防性抗衰老治療帶來的人口多元化和男性消費者的湧入，預計也將為市場帶來可觀的需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球肉毒桿菌市場
• 基於應用領域的細分市場分析，2020-2024 年
• 2020-2024 年最終用戶細分市場分析
• 2020-2024年基於性別的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球肉毒桿菌市場
• 地緣政治衝突對全球肉毒桿菌市場的影響。

第7章：五力分析

第8章 市場區隔：依應用領域

• 比較：透過應用
• 美麗
• 醫學領域
• 市場機會：依應用領域分類

第9章 市場區隔：依最終用戶分類

• 比較：按最終用戶
• 醫院
• 皮膚科診所
• 其他
• 市場機會：依最終用戶分類

第10章 市場區隔：依性別

• 比較：按性別
• 女士
• 男性
• 市場機會：依性別分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 法國
  • 德國
  • 英國
  • 俄羅斯
  • 義大利
  • 西班牙
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 印尼
  • 新加坡
• 世界其他地區（RoW）
  • 巴西
  • 澳洲
  • 沙烏地阿拉伯
  • UAE
  • 南非
  • 智利
  • 以色列
  • 土耳其
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• AbbVie Inc.
• Bausch Health Co Inc.
• China National Biotec Group
• Daewoong Pharmaceutical Co. Ltd.
• Evolus Inc.
• Galderma Group AG
• Hugel Inc.
• Huons Global Co. Ltd.
• Ipsen Pharma
• Medytox Inc.
• Merz Pharma GmbH KGaA
• Object Pharma Inc.
• PharmaResearch Co. Ltd.
• Revance Therapeutics Inc.
• Supernus Pharmaceuticals Inc.

第16章附錄

The global botox market is forecasted to grow by USD 6215.9 mn during 2025-2030, accelerating at a CAGR of 10.7% during the forecast period. The report on the global botox market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating global demand for minimally invasive aesthetic procedures, rapid expansion of approved therapeutic and clinical applications, demographic transitions and rise of preventative geriatric care.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global botox market is segmented as below:

By Application

• Aesthetic
• Medical

By End-User

• Hospitals
• Dermatology clinics
• Others

By Gender

• Female
• Male

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Russia
  • Italy
  • Spain
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the proliferation of ready-to-use liquid formulations and next-generation neuromodulators as one of the prime reasons driving the global botox market growth during the next few years. Also, mainstream integration of full-face contouring and micro-dosing techniques and demographic diversification driven by preventative pre-aging treatments and male consumer influx will lead to sizable demand in the market.

The report on the global botox market covers the following areas:

• Global botox market sizing
• Global botox market forecast
• Global botox market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global botox market vendors that include AbbVie Inc., Bausch Health Co Inc., China National Biotec Group, Croma-Pharma GmbH, Daewoong Pharmaceutical Co. Ltd., Evolus Inc., Galderma Group AG, Hugel Inc., Huons Global Co. Ltd., Ipsen Pharma, Medytox Inc., Merz Pharma GmbH KGaA, Object Pharma Inc., PharmaResearch Co. Ltd., Revance Therapeutics Inc., Supernus Pharmaceuticals Inc.. Also, the global botox market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Gender
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Botox Market 2020 - 2024
  • Historic Market Size - Data Table on Global Botox Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Gender segment analysis 2020 - 2024
  • Historic Market Size - Gender Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global botox market
• 6.2 Impact of geopolitical conflicts on global botox market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 Aesthetic - Market size and forecast 2025-2030
• 8.4 Medical - Market size and forecast 2025-2030
• 8.5 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals - Market size and forecast 2025-2030
• 9.4 Dermatology clinics - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Gender

• 10.1 Market segments
• 10.2 Comparison by Gender
• 10.3 Female - Market size and forecast 2025-2030
• 10.4 Male - Market size and forecast 2025-2030
• 10.5 Market opportunity by Gender
  • Market opportunity by Gender ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 France - Market size and forecast 2025-2030
  • 12.4.2 Germany - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Russia - Market size and forecast 2025-2030
  • 12.4.5 Italy - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Australia - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Chile - Market size and forecast 2025-2030
  • 12.6.7 Israel - Market size and forecast 2025-2030
  • 12.6.8 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Escalating global demand for minimally invasive aesthetic procedures
  • Rapid expansion of approved therapeutic and clinical applications
  • Demographic transitions and rise of preventative geriatric care
• 13.2 Market challenges
  • Proliferation of counterfeit formulations and unlicensed distribution networks
  • Escalating regulatory compliance burdens and intramuscular distribution safeguards
  • Intense pricing pressures and proliferation of low-cost biosimilars
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Proliferation of ready-to-use liquid formulations and next-generation neuromodulators
  • Mainstream integration of full-face contouring and micro-dosing techniques
  • Demographic diversification driven by preventative pre-aging treatments and male consumer influx

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AbbVie Inc.
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key news
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Segment focus
  • SWOT
• 15.5 Bausch Health Co Inc.
  • Bausch Health Co Inc. - Overview
  • Bausch Health Co Inc. - Business segments
  • Bausch Health Co Inc. - Key offerings
  • Bausch Health Co Inc. - Segment focus
  • SWOT
• 15.6 China National Biotec Group
  • China National Biotec Group - Overview
  • China National Biotec Group - Product / Service
  • China National Biotec Group - Key offerings
  • SWOT
• 15.7 Daewoong Pharmaceutical Co. Ltd.
  • Daewoong Pharmaceutical Co. Ltd. - Overview
  • Daewoong Pharmaceutical Co. Ltd. - Product / Service
  • Daewoong Pharmaceutical Co. Ltd. - Key offerings
  • SWOT
• 15.8 Evolus Inc.
  • Evolus Inc. - Overview
  • Evolus Inc. - Product / Service
  • Evolus Inc. - Key offerings
  • SWOT
• 15.9 Galderma Group AG
  • Galderma Group AG - Overview
  • Galderma Group AG - Business segments
  • Galderma Group AG - Key offerings
  • Galderma Group AG - Segment focus
  • SWOT
• 15.10 Hugel Inc.
  • Hugel Inc. - Overview
  • Hugel Inc. - Product / Service
  • Hugel Inc. - Key offerings
  • SWOT
• 15.11 Huons Global Co. Ltd.
  • Huons Global Co. Ltd. - Overview
  • Huons Global Co. Ltd. - Product / Service
  • Huons Global Co. Ltd. - Key offerings
  • SWOT
• 15.12 Ipsen Pharma
  • Ipsen Pharma - Overview
  • Ipsen Pharma - Business segments
  • Ipsen Pharma - Key offerings
  • Ipsen Pharma - Segment focus
  • SWOT
• 15.13 Medytox Inc.
  • Medytox Inc. - Overview
  • Medytox Inc. - Product / Service
  • Medytox Inc. - Key offerings
  • SWOT
• 15.14 Merz Pharma GmbH KGaA
  • Merz Pharma GmbH KGaA - Overview
  • Merz Pharma GmbH KGaA - Product / Service
  • Merz Pharma GmbH KGaA - Key offerings
  • SWOT
• 15.15 Object Pharma Inc.
  • Object Pharma Inc. - Overview
  • Object Pharma Inc. - Product / Service
  • Object Pharma Inc. - Key offerings
  • SWOT
• 15.16 PharmaResearch Co. Ltd.
  • PharmaResearch Co. Ltd. - Overview
  • PharmaResearch Co. Ltd. - Product / Service
  • PharmaResearch Co. Ltd. - Key offerings
  • SWOT
• 15.17 Revance Therapeutics Inc.
  • Revance Therapeutics Inc. - Overview
  • Revance Therapeutics Inc. - Product / Service
  • Revance Therapeutics Inc. - Key offerings
  • SWOT
• 15.18 Supernus Pharmaceuticals Inc.
  • Supernus Pharmaceuticals Inc. - Overview
  • Supernus Pharmaceuticals Inc. - Product / Service
  • Supernus Pharmaceuticals Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations